• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

John Maraganore makes a bold promise ahead of #JPM21 — aiming to take Alnylam into the...

cafead

Administrator
Staff member
  • cafead   Jan 11, 2021 at 11:02: AM
via Alnylam CEO John Maraganore is a big fan of five-year plans, and with JPM21 kicking off this week, he revealed his company’s newest ambitious goal — become a “top 5 biotech” by 2025.

article source
 

<